Analyse Merck stock

Confirmed: The consensus price target of 116.57 EUR is only around 2.9% above the current price of 113.24 EUR and is therefore clearly within the required ±25% plausibility range.
Quantitative: The current P/E ratio of 30.05already signals a challenging valuation, but is still justifiable for a large, profitable, defensive healthcare/life sciences business with structural growth. Compared to the 52-week high of EUR 113.87, the share is practically at the upper edge of the most recent trading range; This limits the upside potential in the short term, but at the same time speaks for a strong trend and positive sentiment.
Fundamen...